Source link : https://newshealth.biz/health-news/safety-of-tofacitinib-vs-biologics-in-psa-one-risk-differs/
Tofacitinib shows safety comparable with biologics for PsA regarding serious infections, myocardial infarction or stroke, and malignancy but is tied to a higher risk for VTE than TNF inhibitors. Medscape Medical News Source link : https://www.medscape.com/viewarticle/safety-tofacitinib-vs-biologics-psoriatic-arthritis-one-risk-2026a1000awg?src=rss Author : Publish date : 2026-04-09 15:50:00 Copyright for syndicated content belongs to the linked Source.
The post Safety of Tofacitinib vs Biologics in PsA: One Risk Differs first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-09 15:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8